Nothing Even Comes Close: No. 1 Canadian Cannabis Stock

It’s time. The trend is strong, and we’ve got confirmation that the bull market has commenced. We’re first in the door – literally.

This is the Canada Marijuana Index, and since July, it has started a breakout.

It’s up 35% since then, and the sector is up over 20%, which officially puts us in bull territory.

What I’m about to hand you today is the key to make incredible returns, effective immediately.

The Overnight Shift: Demand Explosion!

Canada's marijuana market could be worth as much as $9 billion once recreational use launches. That’s 22 times the current size – a 2,200% increase o-v-e-r-n-i-g-h-t!

If that’s not enough, Canada will become the ONLY developed nation in the world with the capacity to export cannabis, at a time when 29 other countries are going through the legalization process, including Germany (Europe’s richest country), Australia, and Argentina.

The strongest companies right out of the gate could become tomorrow’s Amazons of the weed industry, and with worldwide acceptance growing exponentially by the minute due to amazing stories like that of Alexis Bortell, the 12-year-old epileptic girl who has been seizure-free for a couple of years after using oils, the validity of the medical benefits are attracting the best scientists in the world.

This is huge.

What we found after looking at 71 cannabis companies in Canada is one cash-rich, fully-funded cultivator, with licenses already permitted, operations in Alberta and Ontario, a gifted management team, and a roadmap to a billion-dollar valuation in 3 years. Its current market cap is CAD$100M.

It is our No. 1 cannabis company, bar none, and it could potentially soar 1,000% from today’s prices in a mere 3 years, conservatively.

I spoke to founder and CEO Dan Kriznic. Along with Trevor Dixon and Brenda Dixon, management has a cumulative 28% ownership of this company.

The shareholder base couldn’t be healthier. Their sole objective is to unlock the value of their cultivation facilities and dominate Canadian cannabis for both medicinal and recreational uses.

Our due diligence of Invictus MD (TSX-V: IMH & OTC: IVITF) began in March when they were listed on the TSX Venture exchange.

That same month, they closed a CAD$16.1M financing and their Alberta facility, 100% owned, received its ACMPR license, one of only 62 in the nation.

They then attracted institutional investors and raised an additional CAD$25M to accelerate the acquisitions model. They are being very aggressive and laser-focused because they want to harvest and sell into the monstrous demand that is about to occur as the floodgates open in a few months.

The reason our timing is immaculate is because they are about to receive their sales approval and begin to start revving the cash profits machine!

As you can see, the fact that management moved quickly ahead of many of the now-launching competitors has given Invictus MD (TSX-V: IMH & OTC: IVITF) a huge advantage.

They have CAD$27M cash on hand, and their expansion phase is fully funded until 15,000 kg.

There will be ZERO dilution to shareholders in this coming growth period, while the company’s cash flow and bottom line improve every quarter. With 15,000 kg and the industry standard at $19,000 per kilogram, the conservative valuation is CAD$285,000,000, which is 300% higher than today’s market cap. By 2021, their goal is to reach 25,000 kg, which will value the stock price at CAD$5.70. Today, it trades for CAD$1.21.

Once they hit 15,000 kg, the expansion plan kicks into 6th gear, as Dan Kriznic, who has already built companies worth $750M in his career, puts in motion the strategy to reach 50,000 kg and a billion-dollar market cap, doubling the 2021 milestone.

As I see it, we are now getting the opportunity to become shareholders right before the announcement of sales license approval and the expansion phase going into next year's legalization date.

But the full story becomes apparent when you reduce the cash from the balance sheet and look at Enterprise Value.

With a current cap at CAD$100M and CAD$27M at the company’s disposal, the EV is CAD$73M, which means that among its peers, it’s the most undervalued Canadian cannabis stock!

In other words, every institutional investor with deep pockets will notice right away that with the entire universe of cannabis stocks at their disposal, none of them have:

1. Cultivation facilities fully funded for quadrupling current production capability in 3 years.
2. Diversification between Alberta and Ontario.
3. A management team with lots of skin in the game and the right incentives to follow the roadmap to the letter.
4. Absolutely undervalued using every valuation metric out there.

In the U.S., there are already marijuana millionaires who have been alert to special situations and exceptional opportunities to back early-stage companies.

Everyone has ignored Canada, but it is already medicinally legal right now. By this time next year, the country will be fully legalized (including recreational use) and a full-blown shortage in crops could erupt.

The first marijuana ETFs launched recently, and this will add to the attention the media will bring, but for now, Canada’s cannabis market isn’t getting any attention – this is your moment.

The mounting catalysts for Invictus MD (TSX-V: IMH & US: IVITF) to become one of Canada’s leading companies and reach a 10-figure valuation are in place.

Dan Kriznic, the founder, has been responsible for incubating companies in a variety of industries from nominal valuations to over a billion in enterprise value.

He’s a serial business-builder, and after meeting with him face-to-face and speaking with him over the phone for months, it is my opinion that he will be a hundred-millionaire from the legalization boom.

Each decision he has made with regards to adding value to shareholders has been flawless.

Invictus MD is our No. 1 stock suggestion, and it has a clear runway to triple in price, as we see it, in months – not years.

I also want to share with you what management has up their sleeve if operations continue to run like clockwork, as they have up until now.

This is a production profile, which completely blew my mind.

Since the management team has championed how to raise funds brilliantly, it even has the potential to reach 50,000 kg in production without DILUTION, using only warrants for cash injection.

Put differently, Invictus could grow from CAD$100M to around CAD$850M-CAD$1B purely by internal growth.

If that happens, it will be the most sought-after business to own in Canada and will be ranked with the world’s most capital-efficient businesses.

What I think is critical to wrap our minds around is the fact that Canada’s medicinal market is only the tip of the iceberg, and in itself, it’s set to exponentially boom.

Once full legalization hits, Invictus MD (TSX-V: IMH & US: IVITF) will attack the recreational sector like no other company. With the caliber of their board and the tight relationships it has formed with government officials and peer businesses, their acquisitions model will disrupt the industry – they have cash on hand and the willingness of institutions to come in at any moment.

This could truly be your best investment ever.